Physician profile
Shaheen Ul Islam
NPI 1497727739
$22,373.89
in general payments reported to CMS, 2019-2025
21 companies · $2,764 in 2025
The $2,764 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,542 · 2020: $1,851 · 2021: $344 · 2022: $7,039 · 2023: $4,728 · 2024: $1,107 · 2025: $2,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,834 · Food and Beverage: $1,265 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,834.03 |
| Food and Beverage | $1,264.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $7,340.00 | 2019-2022 | |
| Pinnacle Biologics, INC | $6,971.58 | 2019-2023 | Photofrin |
| Intuitive Surgical, INC. | $1,684.15 | 2019-2025 | |
| Body Vision Medical INC. | $1,585.63 | 2023 | Lungvision |
| Medical Device Business Services, INC. | $1,201.89 | 2025 | Monarch |
| Pulmonx Corporation | $942.75 | 2019-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Medtronic, INC. | $772.25 | 2024 | Illumisite |
| Coaptech, INC. | $748.26 | 2025 | Puma System |
| Cook Medical LLC | $341.81 | 2021-2022 | |
| Ethicon INC. | $278.47 | 2023-2025 | Monarch Platform |
| Astrazeneca Pharmaceuticals Lp | $177.04 | 2025 | |
| Steris Corporation | $89.02 | 2025 | |
| Inari Medical, INC. | $50.51 | 2022 | |
| Shionogi INC | $34.51 | 2023 | Fetroja |
| Actelion Pharmaceuticals US, INC. | $29.82 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $26.73 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.66 | 2023 | |
| United Therapeutics Corporation | $21.80 | 2022 | |
| Olympus America INC. | $21.44 | 2024 | Single-Use Flexible Video Bronchoscope |
| Aurinia Pharma U.S., INC. | $17.80 | 2023 | Lupkynis |
| Mylan Specialty L.P. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaheen Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.